Welcome to the international HTA database

Showing [24105 Records] Selected Records [0 Hits] [Clear]

Year	Source	Title
2019	Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)	[Negative pressure wound therapy for wounds healing by primary intention]
2008	Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)	[Negative pressure wound therapy - rapid report]
2017	Institute for Clinical Effectiveness and Health Policy (IECS)	[Negative pressure therapy in chronic wounds]
2015	Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS)	[Needs assessment and development of an information material for patients with sarcoidosis]
2016	Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)	[Necitumumab (lung cancer) - Addendum to Commission A16-17]
2016	Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)	[Necitumumab - Benefit assessment according to §35a Social Code Book V]
2015	National Evidence-based Healthcare Collaborating Agency (NECA)	[NECA Round Table Conference for social consensus]
2020	Institut national d'excellence en sante et en services sociaux (INESSS)	[National medical protocols and associated prescriptions: pharmacological treatment for fecal elimination in a person receiving palliative care or presenting a geriatric profile]
2020	Institut national d'excellence en sante et en services sociaux (INESSS)	[National medical protocols and associated prescriptions: initiating a blood profile after detecting suggestive symptoms and signs of mild or major neurocognitive disorder]
2020	Institut national d'excellence en sante et en services sociaux (INESSS)	[National medical protocols and associated prescriptions: first-line treatment of oral candidiasis in adults]
2019	Institut national d'excellence en sante et en services sociaux (INESSS)	[National medical protocols and associated prescriptions: antidiabetics]
2019	Institut national d'excellence en sante et en services sociaux (INESSS)	[National medical protocols and associated prescriptions: anticoagulant therapy]
2019	Institut national d'excellence en sante et en services sociaux (INESSS)	[National medical protocols and associated prescriptions: acute exacerbation of chronic obstructive pulmonary disease]
2019	Institut national d'excellence en sante et en services sociaux (INESSS)	[National medical protocols and associated prescriptions, updated June 2019: palliative care - fever]
2019	Institut national d'excellence en sante et en services sociaux (INESSS)	[National medical protocols and associated prescriptions, updated in October 2019: lipid-lowering pharmacologic agents]
2019	Institut national d'excellence en sante et en services sociaux (INESSS)	[National medical protocols and associated prescriptions, updated in June 2019: urethral discharge]
2019	Institut national d'excellence en sante et en services sociaux (INESSS)	[National medical protocols and associated prescriptions, updated in June 2019: unusual vaginal discharge]
2019	Institut national d'excellence en sante et en services sociaux (INESSS)	[National medical protocols and associated prescriptions, updated in June 2019: acute exacerbations of chronic obstructive pulmonary disease (AECOPD)]
2019	Institut national d'excellence en sante et en services sociaux (INESSS)	[National medical protocols and associated prescriptions, updated in July 2019: high blood pressure]
2019	Institut national d'excellence en sante et en services sociaux (INESSS)	[National medical protocols and associated prescriptions, updated in August 2020: pharmacological treatment of nausea in a person receiving palliative care]
2020	Institut national d'excellence en sante et en services sociaux (INESSS)	[National medical protocols and associated prescriptions, updated in August 2020: administration of drugs prescribed via an individual prescription in the event of distress for a person receiving palliative care]
2021	German Agency for Health Technology Assessment at the German Institute for Medical Documentation and Information (DAHTA DIMDI)	[National expert standards in nursing care]
2021	Norwegian Institute of Public Health (NIPH)	[Natalizumab subcutaneous for the treatment of relapsing remitting multiple sclerosis: a rapid health technology assessment - health economic evaluation]
2018	Institute for Clinical Effectiveness and Health Policy (IECS)	[Natalizumab for recurrent-remitting and JC virus seropositive multiple sclerosis]
2018	Institute for Clinical Effectiveness and Health Policy (IECS)	[Narrow band imaging (NBI) in diagnostic gastrointestinal endoscopy]
2010	Andalusian Health Technology Assessment Area (AETSA)	[Nanotechnology in medicine]
2014	Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)	[Nalmefene - Benefit assessment according to §35a Social Code Book V (dossier assessment)]
2020	Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)	[Naldemedine (opioid-induced constipation) - Benefit assessment according to §35a Social Code Book V]
2020	Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)	[Naldemedine (opioid-induced constipation) - Addendum to Commission A20-45]
2018	Institute for Clinical Effectiveness and Health Policy (IECS)	[Nabiximols for spasticity and chronic pain]
2015	Institute for Clinical Effectiveness and Health Policy (IECS)	[Nab-paclitaxel (Abraxane) for the treatment of metastatic pancreatic cancer]
2023	Austrian Institute for Health Technology Assessment (AIHTA)	[Myopia control spectacle lenses for children and adolescents]
2023	Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)	[Myomectomy versus no treatment - Evidence report for the S3 guideline on diagnosis and treatment of benign diseases of the uterus]
2024	Canary Health Service	[Myofunctional therapy (oropharyngeal exercises) for obstructive sleep apnea]
2009	Committee for New Health Technology Assessment (CNHTA)	[MUTYH gene mutation[Sequencing]]
2013	German Agency for Health Technology Assessment at the German Institute for Medical Documentation and Information (DAHTA DIMDI)	[Music therapy in palliative setting]
2018	Institute for Clinical Effectiveness and Health Policy (IECS)	[Music therapy in children with developmental disorders]
2021	German Agency for Health Technology Assessment at the German Institute for Medical Documentation and Information (DAHTA DIMDI)	[Music therapy for adolescents with mental and behavioural disorders]
2013	Institute for Clinical Effectiveness and Health Policy (IECS)	[Music therapy - update on the evidence about its indications]
2022	HTA South	[Music intervention for adult intensive care patients]
2023	Norwegian Institute of Public Health (NIPH)	[Mupirocin nasal ointment as infection prevention prophylaxis prior to orthopaedic prosthesis surgery: a rapid health technology assessment]
2023	Institute for Clinical Effectiveness and Health Policy (IECS)	[Multiplex PCR for moderate to severe acute lower respiratory tract infections]
2021	Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)	[Multiple sclerosis: does the use of mHealth solutions (e.g. apps) lead to better results in the self-management of those affected?]
2021	Swedish Agency for Health Technology Assessment and Assessment of Social Services (SBU)	[Multimodal and interdisciplinary interventions for long term pain]
2023	Institute for Clinical Effectiveness and Health Policy (IECS)	[Multigene panel testing for tumors of known origin]
2010	Danish Centre for Evaluation and Health Technology Assessment (DACEHTA)	[Multidisciplinary and multisectoral interventions targeting patients with back pain]
2010	Danish Centre for Evaluation and Health Technology Assessment (DACEHTA)	[Multidisciplinary and multisectoral interventions targeting patients with back pain – a health technology assessment]
2012	Basque Office for Health Technology Assessment (OSTEBA)	[Multicentre study to analyse the effectiveness of telemedicine in spirometry quality assurance programmes]
2012	The Netherlands Organisation for Health Research and Development (ZonMw)	[Multicentered randomized controlled trial to test the cost effectiveness of urodynamics in women with symptoms of stress urinary incontinence in whom surgical treatment is considered]
2024	Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)	[Multi-stage evaluation and revision of information materials on the mammography screening programme]
2008	Andalusian Health Technology Assessment Area (AETSA)	[Multi-slice computerised tomography coronary angiography in detecting coronary stenosis. Meta-analysis and economic report]
2006	Andalusian Health Technology Assessment Area (AETSA)	[Multi-slice computerised tomography coronary angiography in detecting coronary stenosis. Meta-analysis and economic report]
2008	Andalusian Health Technology Assessment Area (AETSA)	[Multi-slice computerised tomography coronary angiography in detecting coronary stenosis. Meta-analysis and economic report.]
2007	The Netherlands Organisation for Health Research and Development (ZonMw)	[MSCT coronary angiography in patients with stable and unstable angina: a multicenter study]
2011	Haute Autorite de sante (HAS)	[MRI-guided vacuum-assisted breast biopsy (VABB)]
2013	Institute for Clinical Effectiveness and Health Policy (IECS)	[MRI enterography for the assessment of inflammatory bowel disease]
2017	Institute for Clinical Effectiveness and Health Policy (IECS)	[Motorized Intramedullary nails for bone lenghtening in achondroplasia or hypochondropasia]
2018	Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)	[Motor-driven continuous passive motion (CPM) devices after interventions on the knee and shoulder joint]
2010	Institute for Clinical Effectiveness and Health Policy (IECS)	[Motor rehabilitation using ARMEO]
2009	Committee for New Health Technology Assessment (CNHTA)	[Motor cortex stimulation]
2011	Norwegian Knowledge Centre for the Health Services (NOKC)	[Motivational interviewing for HIV-related behaviors among men who have sex with men]
2009	The Netherlands Organisation for Health Research and Development (ZonMw)	[Motivational interviewing embedded in planned diabetes care for Type 2 patients: effectiveness and efficiency in general practice especially to improve guideline recommendations on diet and exercise]
2022	Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)	[Mosunetuzumab (follicular lymphoma) - Assessment according to §35a (para. 1, sentence 11) Social Code Book V]
2009	The Netherlands Organisation for Health Research and Development (ZonMw)	[More efficient use of corneal donor donations: the Dutch Lamellar Corneal Transplantation Study (DLCTS-Study)]
2018	Institute for Clinical Effectiveness and Health Policy (IECS)	[Montelukast in patients with chronic allergic rhinitis and no asthma]
2024	National Evidence-based Healthcare Collaborating Agency (NECA)	[Monocyte distribution width, MDW]
2013	Andalusian Health Technology Assessment Area (AETSA)	[Monoclonal antibodies associated with chemotherapy as first line therapy in metastatic colorectal cancer: relative efficacy, safety and efficiency]
2020	Canary Health Service	[Monitoring study: “Endobronchial valves for persistent air leak”]
2021	Canary Health Service	[Monitoring study: "The sensor glucose monitoring system (flash-type) for type 1 diabetes mellitus in childhood and adolescence"]
2015	Canary Health Service	[Monitoring study protocol (part I): endobronchial valves for persistent air leakage]
2008	The Netherlands Organisation for Health Research and Development (ZonMw)	[Monitoring of stable glaucoma patients: evaluation of the effectiveness and efficiency of a glaucoma follow-up unit, staffed by nonphysician health care professionals, as an intermediate step towards glaucoma monitoring in primary care]
2009	The Netherlands Organisation for Health Research and Development (ZonMw)	[Monitoring of exhaled nitric oxide (FENO) to tailor the lowest effective dose of oral corticosteroids in severe asthma (MONOSA-Study)]
2007	Danish Centre for Evaluation and Health Technology Assessment (DACEHTA)	[Monitoring depth of anaesthesia - a health technology assessment]
2015	Canary Health Service	[Monetary value of a quality-adjusted life year: empirical estimation of the opportunity cost in the national health system]
2014	Canary Health Service	[Monetary value of a quality-adjusted life year: a critical review and appraisal of the literature]
2024	Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)	[Momelotinib (myelofibrosis) – Assessment according to §35a (para. 1, sentence 11) Social Code Book V]
2024	Canary Health Service	[Molecular urine-based biomarkers for the diagnosis of urothelial carcinoma]
2023	Health Sciences Institute in Aragon (IACS)	[Molecular study of common apoE gene polymorphisms associated with familial dysbetalipoproteinaemia and late-onset Alzheimer’s disease]
2021	Canary Health Service	[Molecular markers for the detection of clinically significant prostate cancer]
2011	The Swedish Council on Health Technology Assessment (SBU)	[Molecular diagnostic tests for men at higher probability for prostate cancer]
2024	Agència de Qualitat i Avaluació Sanitàries de Catalunya (AQuAS)	[Molecular characterization of central nervous system tumors by (next-generation sequencing, NGS). Evaluation of diagnostic and prognostic utility and implementation considerations]
2020	Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)	[Mogamulizumab (mycosis fungoides or Sézary syndrome) - Assessment according to §35a (para. 1., sentence 11) Social Code Book V]
2015	Haute Autorite de sante (HAS)	[Modification of the nomenclature of procedures in laboratory medicine for research into Treponema pallidum (bacteria responsible for syphilis)]
2008	Basque Office for Health Technology Assessment (OSTEBA)	[Models of lower back pain: reliability of a classification model]
2013	Basque Office for Health Technology Assessment (OSTEBA)	[Models of collaboration and intervention between primary care and mental health in the care of patients diagnosed with depression: results of a meta-review]
2016	Institut national d'excellence en sante et en services sociaux (INESSS)	[Models for providing care and services to patients who have concurrent mental health and substance use disorders]
2022	Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)	[Mobility disorders: does the Feldenkrais method help?]
2023	Institute for Clinical Effectiveness and Health Policy (IECS)	[Mobile cardiopulmonary exercise test in athletes or cardiopulmonary rehabilitation]
2021	German Agency for Health Technology Assessment at the German Institute for Medical Documentation and Information (DAHTA DIMDI)	[Mistletoe therapy with breast cancer]
2009	Norwegian Knowledge Centre for the Health Services (NOKC)	[Misoprostol for induction of labour]
2021	Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)	[Misoprostol (induction of labour) - Benefit assessment according to §35a Social Code Book V]
2022	Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)	[Misoprostol (induction of labour) - Benefit assessment according to §35a Social Code Book V]
2025	Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)	[Mirvetuximab soravtansin (ovarian cancer) – assessment in accordance with §35a (1) Sentence 11 Social Code Book (SGB) V]
2023	Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)	[Mirikizumab (ulcerative colitis) - Benefit assessment according to § 35a Social Code Book V]
2025	Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)	[Mirikizumab (Crohn’s disease) – Benefit assessment according to §35a Social Code Book V]
2020	National Committee for Technology Incorporation (CONITEC)	[Mirabegron for the treatment of storage dysfunction in patients with neurogenic bladder]
2014	Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)	[Mirabegron - Benefit assessment according to §35a Social Code Book V (dossier assessment)]
2003	Basque Office for Health Technology Assessment (OSTEBA)	[Minimum characteristics of a cardiac rehabilitation programme in the Basque Autonomous Community]
2025	Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)	[Mindfulness-based stress reduction: Evidence report for the S3 guideline on the definition, causes, diagnosis and treatment of fibromyalgia syndrome]
2024	National Evidence-based Healthcare Collaborating Agency (NECA)	[Migraine surgery]